Description: Session 1G: Rethinking Catastrophic Claims - Strategies for Sustainable Stop-Loss Pricing

Description: Session 4A: Downwind of the Unwind - Medicaid PHE Unwind Impacts on Acuity and Other Actuarial Challenges

Description: Session 10E: Regulatory Changes in Supplemental Health With an Actuarial Lens

Description: Session 9C: Adventures in AI - Group Insurance Perspectives

Description: Session 7D: Medicare Coverage of GLP-1's - Trimming the Fat

Description: Session 9E: The ACA Marketplace and 1332 Waiver State Innovation Programs

Description: Session 4D: A Year of Change for Medicare Advantage

Description: Pharmacy continues to be one of, if not the, fastest growing services in both public and private health plans. Between new blockbuster drugs and gene therapies coming to the market at a record pace expanded indications for drugs already on the market, and rapid cost inflation across numerous therapeutic categories, plan sponsors are constantly looking for new and innovative ways to keep pharmacy costs under control.

Description: The objective of this session is to explore the fast-growing segment of healthcare that is provider enablement. Value-based care (VBC) in its original form was an alignment between providers and payers to deliver on the triple aim of cost of care, experience of care, and health of populations (more recently the quintuple aim including health equity and provider experience).

Description: This session will provide an overview of the challenges found in understanding and managing the medical drug benefit based on standard claims data. Participants will learn what makes coding medical drugs challenging and how to navigate some of the pitfalls when conducting analyses on this important segment of utilization and cost trend.